$CLDX Recent Headlines Stock leaders flex muscle
Post# of 94181
Posted On: 03/03/2014 11:49:17 AM
$CLDX Recent Headlines
Stock leaders flex muscles 1:58 p.m. Feb. 27, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 11:28 a.m. Feb. 24, 2014 - Michael Ashbaugh
This tiny mutual fund is no. 1 for 2013 7:33 a.m. Jan. 7, 2014 - Suzanne McGee
Reading Wall Street’s tea leaves 2:44 p.m. Dec. 6, 2013 - The Trading Deck
Monthly jobs report triggers technical whipsaw 11:23 a.m. Sept. 6, 2013 - Michael Ashbaugh
Charting a market divergence 10:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Six stocks on the move 1:42 p.m. Aug. 21, 2013 - The Trading Deck
Charting a slow-motion test of major resistance 10:10 a.m. July 3, 2013 - Michael Ashbaugh
S&P 500 hesitates at the breakdown point 10:14 a.m. June 26, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 2:22 p.m. June 12, 2013 - The Trading Deck
3 longs and 3 shorts to watch 1:33 p.m. April 17, 2013 - The Trading Deck
Hedge Funds have bought these stocks recently 2:04 p.m. April 12, 2013 - Insider Monkey
Hedge funds are bullish on these 5 stocks 7:38 a.m. Jan. 3, 2013 - Insider Monkey
Thursday’s top gaining and declining stocks 2:24 p.m. May 24, 2012 - MarketWatch
Friday’s biggest gaining and declining stocks 4:40 p.m. Feb. 24, 2012 - Kate Gibson
Celldex prices shares at 12% discount 11:26 a.m. Feb. 24, 2012 - MarketWatch.com
Rindopepimut ups brain cancer survival: Celdex 2:29 p.m. Nov. 21, 2011 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 2:33 p.m. May 18, 2011 - Kate Gibson
Celldex, Shire in drug-sector spotlight 12:35 p.m. May 18, 2011 - Val Brickates Kennedy
Celldex Therapeutics offer prices at 19% discount 8:48 a.m. May 18, 2011 - MarketWatch.com
10-K: CELLDEX THERAPEUTICS, INC. 10 min ago - Edgar Online - (EDG = 10Q, 10K)
Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due 10:32 a.m. Today - TheStreet.com
Celldex Therapeutics, Inc Discusses Q1 2014 Results (Webcast) 8:25 a.m. Today - Seeking Alpha
Eotaxin-1 Inhibition - The Next PD(L)-1 In Inflammatory Disease? 10:23 a.m. Feb. 21, 2014 - Seeking Alpha
Catalysts Drive These Stocks: Mara Goldstein 9:20 a.m. Feb. 21, 2014 - Seeking Alpha
Agenus: Acquisition Of 4-Antibody Is A Transformational Move 1:28 p.m. Feb. 20, 2014 - Seeking Alpha
Celldex Therapeutics Inc. (CLDX): Today's Featured Health Care Laggard 5:01 p.m. Feb. 13, 2014 - TheStreet.com
Use Options For A Chance To Buy CLDX At A 62% Discount 11:42 a.m. Feb. 13, 2014 - TheStreet.com
Do Away With The Pill-A-Day Biotech Model: Steve Brozak 2:05 p.m. Feb. 7, 2014 - Seeking Alpha
Combination Therapies: Where Immuno-Oncology Is Headed And How To Invest 8:55 a.m. Feb. 6, 2014 - Seeking Alpha
Seattle Genetics Will Exceed And Immunogen Will Meet Market Expectations 11:09 a.m. Jan. 25, 2014 - Seeking Alpha
First Week Of March 22nd Options Trading For Celldex Therapeutics (CLDX) 1:20 p.m. Jan. 22, 2014 - TheStreet.com
Cramer's Mad Money - 10 Trends Moving Stocks (1/21/14) 6:17 a.m. Jan. 22, 2014 - Seeking Alpha
Sell Watch: Zeltiq Has Become Over-Speculated 9:20 a.m. Jan. 21, 2014 - Seeking Alpha
Use Options For A Chance To Buy CLDX At A 58% Discount 11:43 a.m. Jan. 15, 2014 - TheStreet.com
Cantor Fitzgerald Shows Best Global Equity Research Ideas for 2014 8:00 a.m. Jan. 15, 2014 - 247WallSt.com
5 Biotech Stocks With Big Catalysts on the Horizon 3:26 a.m. Jan. 15, 2014 - InvestorPlace.com
Best Biotech Ideas for 2014 1:35 p.m. Jan. 11, 2014 - Barrons.com
Celldex Therapeutics: Can an Orphan Program Create Larger Gains? 11:17 a.m. Jan. 8, 2014 - Wall St. Cheat Sheet
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More 7:46 a.m. Jan. 7, 2014 - 247WallSt.com
Celldex Reports Fiscal 2013 Business/Financial Results and Outlines 2014 Strategy 8:03 a.m. Today - GlobeNewswire
Celldex to Report Fourth Quarter and Fiscal 2013 Business/Financial Results and Host 2014 Strategy Conference Call 1:30 p.m. Feb. 25, 2014 - GlobeNewswire
Critical Alerts For AT&T, Mastercard, Disney, Du Pont, and Celldex Therapeutics Released By InvestorsObserver 9:31 a.m. Feb. 12, 2014 - PR Newswire - PRF
Celldex Announces Upcoming Presentation at the 2014 Leerink Global Healthcare Conference 11:00 a.m. Feb. 6, 2014 - GlobeNewswire
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013 11:02 a.m. Jan. 21, 2014 - BusinessWire - BZX
Critical Alerts For Facebook, DirecTV, Du Pont, BIDU, and Celldex Released By InvestorsObserver 9:31 a.m. Jan. 9, 2014 - PR Newswire
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 8:00 a.m. Jan. 9, 2014 - PR Newswire
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind 8:00 a.m. Dec. 31, 2013 - PR Newswire
Health Care Sector Technical Data: XOMA, Celldex Therapeutics, Illumina, and Immunomedics 8:12 a.m. Dec. 19, 2013 - PR Newswire
Share Price Movements and Clinical Studies - Research Report on Celldex Therapeutics, Envision, MannKind, Covance, and Auxilium 8:00 a.m. Dec. 19, 2013 - PR Newswire
Clinical Trial Results, Partnerships, and Reimbursement Rates - Research Report on Celldex, Centene, Enanta, Novartis, and BG Medicine 8:00 a.m. Dec. 13, 2013 - PR Newswire
New Clinical Trials, Pricing of Common Stock and Adjusted Conversion of Convertible Senior Notes - Research Report on Regeneron, Celldex, PDL BioPharma, Amedisys, and Exelixis 8:00 a.m. Dec. 11, 2013 - PR Newswire
Celldex's CDX-301 in Combination with Mozobil(R) Increases Hematopoietic Stem Cell Mobilization and Results in Improved Transplantation of Mobilized Cells in Preclinical Studies; Results Presented at ASH 2013 8:30 a.m. Dec. 10, 2013 - GlobeNewswire
Celldex Announces Exercise of Underwriters' Option to Purchase Additional Shares 5:03 p.m. Dec. 9, 2013 - GlobeNewswire
Stock Price Movements, Campaigns, New Clinical Studies, and Approvals- Research Report on Actavis, Ariad Pharmaceuticals, DaVita, Celldex, and WellCare 8:00 a.m. Dec. 5, 2013 - PR Newswire
Celldex Therapeutics Prices Public Offering of Common Stock 7:52 p.m. Dec. 4, 2013 - GlobeNewswire
Celldex Therapeutics Announces Proposed Public Offering of Common Stock 4:05 p.m. Dec. 3, 2013 - GlobeNewswire
Celldex Therapeutics Initiates METRIC, an Accelerated Approval Study of Glembatumumab Vedotin in Patients with Triple Negative Breast Cancer 7:00 a.m. Dec. 2, 2013 - GlobeNewswire
Celldex Announces Upcoming Presentation at the Deutsche Bank 2013 BioFEST 8:03 a.m. Nov. 27, 2013 - GlobeNewswire
Critical Alerts For Google, Philip Morris, Lockheed Martin, Celldex Therapeutics, and Anglogold Ashanti Released By InvestorsObserver 9:31 a.m. Nov. 26, 2013 - PR Newswire
Stock leaders flex muscles 1:58 p.m. Feb. 27, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 11:28 a.m. Feb. 24, 2014 - Michael Ashbaugh
This tiny mutual fund is no. 1 for 2013 7:33 a.m. Jan. 7, 2014 - Suzanne McGee
Reading Wall Street’s tea leaves 2:44 p.m. Dec. 6, 2013 - The Trading Deck
Monthly jobs report triggers technical whipsaw 11:23 a.m. Sept. 6, 2013 - Michael Ashbaugh
Charting a market divergence 10:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Six stocks on the move 1:42 p.m. Aug. 21, 2013 - The Trading Deck
Charting a slow-motion test of major resistance 10:10 a.m. July 3, 2013 - Michael Ashbaugh
S&P 500 hesitates at the breakdown point 10:14 a.m. June 26, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 2:22 p.m. June 12, 2013 - The Trading Deck
3 longs and 3 shorts to watch 1:33 p.m. April 17, 2013 - The Trading Deck
Hedge Funds have bought these stocks recently 2:04 p.m. April 12, 2013 - Insider Monkey
Hedge funds are bullish on these 5 stocks 7:38 a.m. Jan. 3, 2013 - Insider Monkey
Thursday’s top gaining and declining stocks 2:24 p.m. May 24, 2012 - MarketWatch
Friday’s biggest gaining and declining stocks 4:40 p.m. Feb. 24, 2012 - Kate Gibson
Celldex prices shares at 12% discount 11:26 a.m. Feb. 24, 2012 - MarketWatch.com
Rindopepimut ups brain cancer survival: Celdex 2:29 p.m. Nov. 21, 2011 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 2:33 p.m. May 18, 2011 - Kate Gibson
Celldex, Shire in drug-sector spotlight 12:35 p.m. May 18, 2011 - Val Brickates Kennedy
Celldex Therapeutics offer prices at 19% discount 8:48 a.m. May 18, 2011 - MarketWatch.com
10-K: CELLDEX THERAPEUTICS, INC. 10 min ago - Edgar Online - (EDG = 10Q, 10K)
Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due 10:32 a.m. Today - TheStreet.com
Celldex Therapeutics, Inc Discusses Q1 2014 Results (Webcast) 8:25 a.m. Today - Seeking Alpha
Eotaxin-1 Inhibition - The Next PD(L)-1 In Inflammatory Disease? 10:23 a.m. Feb. 21, 2014 - Seeking Alpha
Catalysts Drive These Stocks: Mara Goldstein 9:20 a.m. Feb. 21, 2014 - Seeking Alpha
Agenus: Acquisition Of 4-Antibody Is A Transformational Move 1:28 p.m. Feb. 20, 2014 - Seeking Alpha
Celldex Therapeutics Inc. (CLDX): Today's Featured Health Care Laggard 5:01 p.m. Feb. 13, 2014 - TheStreet.com
Use Options For A Chance To Buy CLDX At A 62% Discount 11:42 a.m. Feb. 13, 2014 - TheStreet.com
Do Away With The Pill-A-Day Biotech Model: Steve Brozak 2:05 p.m. Feb. 7, 2014 - Seeking Alpha
Combination Therapies: Where Immuno-Oncology Is Headed And How To Invest 8:55 a.m. Feb. 6, 2014 - Seeking Alpha
Seattle Genetics Will Exceed And Immunogen Will Meet Market Expectations 11:09 a.m. Jan. 25, 2014 - Seeking Alpha
First Week Of March 22nd Options Trading For Celldex Therapeutics (CLDX) 1:20 p.m. Jan. 22, 2014 - TheStreet.com
Cramer's Mad Money - 10 Trends Moving Stocks (1/21/14) 6:17 a.m. Jan. 22, 2014 - Seeking Alpha
Sell Watch: Zeltiq Has Become Over-Speculated 9:20 a.m. Jan. 21, 2014 - Seeking Alpha
Use Options For A Chance To Buy CLDX At A 58% Discount 11:43 a.m. Jan. 15, 2014 - TheStreet.com
Cantor Fitzgerald Shows Best Global Equity Research Ideas for 2014 8:00 a.m. Jan. 15, 2014 - 247WallSt.com
5 Biotech Stocks With Big Catalysts on the Horizon 3:26 a.m. Jan. 15, 2014 - InvestorPlace.com
Best Biotech Ideas for 2014 1:35 p.m. Jan. 11, 2014 - Barrons.com
Celldex Therapeutics: Can an Orphan Program Create Larger Gains? 11:17 a.m. Jan. 8, 2014 - Wall St. Cheat Sheet
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More 7:46 a.m. Jan. 7, 2014 - 247WallSt.com
Celldex Reports Fiscal 2013 Business/Financial Results and Outlines 2014 Strategy 8:03 a.m. Today - GlobeNewswire
Celldex to Report Fourth Quarter and Fiscal 2013 Business/Financial Results and Host 2014 Strategy Conference Call 1:30 p.m. Feb. 25, 2014 - GlobeNewswire
Critical Alerts For AT&T, Mastercard, Disney, Du Pont, and Celldex Therapeutics Released By InvestorsObserver 9:31 a.m. Feb. 12, 2014 - PR Newswire - PRF
Celldex Announces Upcoming Presentation at the 2014 Leerink Global Healthcare Conference 11:00 a.m. Feb. 6, 2014 - GlobeNewswire
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013 11:02 a.m. Jan. 21, 2014 - BusinessWire - BZX
Critical Alerts For Facebook, DirecTV, Du Pont, BIDU, and Celldex Released By InvestorsObserver 9:31 a.m. Jan. 9, 2014 - PR Newswire
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 8:00 a.m. Jan. 9, 2014 - PR Newswire
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind 8:00 a.m. Dec. 31, 2013 - PR Newswire
Health Care Sector Technical Data: XOMA, Celldex Therapeutics, Illumina, and Immunomedics 8:12 a.m. Dec. 19, 2013 - PR Newswire
Share Price Movements and Clinical Studies - Research Report on Celldex Therapeutics, Envision, MannKind, Covance, and Auxilium 8:00 a.m. Dec. 19, 2013 - PR Newswire
Clinical Trial Results, Partnerships, and Reimbursement Rates - Research Report on Celldex, Centene, Enanta, Novartis, and BG Medicine 8:00 a.m. Dec. 13, 2013 - PR Newswire
New Clinical Trials, Pricing of Common Stock and Adjusted Conversion of Convertible Senior Notes - Research Report on Regeneron, Celldex, PDL BioPharma, Amedisys, and Exelixis 8:00 a.m. Dec. 11, 2013 - PR Newswire
Celldex's CDX-301 in Combination with Mozobil(R) Increases Hematopoietic Stem Cell Mobilization and Results in Improved Transplantation of Mobilized Cells in Preclinical Studies; Results Presented at ASH 2013 8:30 a.m. Dec. 10, 2013 - GlobeNewswire
Celldex Announces Exercise of Underwriters' Option to Purchase Additional Shares 5:03 p.m. Dec. 9, 2013 - GlobeNewswire
Stock Price Movements, Campaigns, New Clinical Studies, and Approvals- Research Report on Actavis, Ariad Pharmaceuticals, DaVita, Celldex, and WellCare 8:00 a.m. Dec. 5, 2013 - PR Newswire
Celldex Therapeutics Prices Public Offering of Common Stock 7:52 p.m. Dec. 4, 2013 - GlobeNewswire
Celldex Therapeutics Announces Proposed Public Offering of Common Stock 4:05 p.m. Dec. 3, 2013 - GlobeNewswire
Celldex Therapeutics Initiates METRIC, an Accelerated Approval Study of Glembatumumab Vedotin in Patients with Triple Negative Breast Cancer 7:00 a.m. Dec. 2, 2013 - GlobeNewswire
Celldex Announces Upcoming Presentation at the Deutsche Bank 2013 BioFEST 8:03 a.m. Nov. 27, 2013 - GlobeNewswire
Critical Alerts For Google, Philip Morris, Lockheed Martin, Celldex Therapeutics, and Anglogold Ashanti Released By InvestorsObserver 9:31 a.m. Nov. 26, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼